Search
for
Sort by
Research 30 of 1000+
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
- Alopecia areata mit gutem Ansprechen auf Tofacitinib
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- In vivo Study of the Effect of 5 and 10% Nebivolol Cream on Hair Growth in Mice Models
- Alopecia universalis successfully treated with tofacitinib
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Clinical Case of Tofacitinib Therapy in Autoimmune Alopecia in Patient with Ulcerative Colitis
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature